FDA Approves Gene Therapy for Kids as Young as 2

Children as young as two can now receive a groundbreaking gene therapy that offers a potential cure for sickle cell disease.

The FDA's approval of Casgevy marks a historic expansion that could prevent irreversible damage before it starts.